Magle Chemoswed Holding AB (publ) (STO: MAGLE)
Sweden
· Delayed Price · Currency is SEK 34.00
+0.80 (2.41%)
Dec 20, 2024, 4:19 PM CET
STO: MAGLE Revenue
Magle Chemoswed Holding AB had revenue of 66.74M SEK in the quarter ending September 30, 2024, with 82.15% growth. This brings the company's revenue in the last twelve months to 209.21M, up 30.82% year-over-year. In the year 2023, Magle Chemoswed Holding AB had annual revenue of 171.50M with 15.89% growth.
Revenue (ttm)
209.21M
Revenue Growth
+30.82%
P/S Ratio
1.76
Revenue / Employee
1.42M
Employees
78
Market Cap
625.67M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.14B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Bonesupport Holding AB (publ) | 814.46M |